- Oklo's small modular reactor achieves criticality, a major technical milestone.
- The milestone aligns with U.S. goals to expand nuclear capacity to 400 GW by 2050.
- Progress under the DOE Reactor Pilot Program signals momentum for next-generation nuclear tech.
A Critical Step Forward
Oklo announced that its Groves Isotope Test Reactor has reached criticality, achieving a self-sustaining nuclear chain reaction for the first time. The milestone, part of the Department of Energy's Reactor Pilot Program, marks a significant step toward commercial deployment of small modular reactors (SMRs) in the U.S., where no such reactors are yet operating commercially.
The Texas-based company, known for its Aurora and Super driver reactor programs, has been steadily advancing through regulatory approvals. The DOE's safety reviews and design agreements have positioned Oklo for startup, with July 2026 cited as a target window for broader criticality milestones.
Policy and Market Implications
The achievement underscores the White House's push to accelerate advanced nuclear technology, which includes an ambitious goal of adding 400 gigawatts of nuclear capacity by 2050. Industry watchers see this as a signal of policy momentum for early-stage commercializable reactors, potentially attracting further investment.
Oklo's progress adds momentum to the U.S. nuclear innovation sector, with related activities such as isotope production and collaborative reactor development gaining traction. The DOE's Reactor Pilot Program aims to have multiple advanced reactors reach criticality by July 4, 2026, fast-tracking licensing for new designs.
While specifics on leadership changes or detailed financials were not disclosed, the company's trajectory appears promising. Efforts to reach Oklo for additional comment were unsuccessful at press time. This is a developing story; updates will be provided as more information becomes available.